April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
HPP-EPC Characterization And The Potential Role In Retinopathy Of Prematurity
Author Affiliations & Notes
  • Qi Yan
    Department of Pediatrics, Baylor College of Medicine, Houston, Texas
    Department of Physiology, Xiang Ya Medical College, Central South University, Changsha, China
  • Qiru Wang
    Department of Physiology, Xiang Ya Medical College, Central South University, Changsha, China
  • Xanthi Couroucli
    Department of Pediatrics, Baylor College of Medicine, Houston, Texas
  • Footnotes
    Commercial Relationships  Qi Yan, None; Qiru Wang, None; Xanthi Couroucli, None
  • Footnotes
    Support  National NSF China 39970092
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 3183. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Qi Yan, Qiru Wang, Xanthi Couroucli; HPP-EPC Characterization And The Potential Role In Retinopathy Of Prematurity. Invest. Ophthalmol. Vis. Sci. 2011;52(14):3183.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Retinopathy of prematurity (ROP) is a disease that affects immature vasculature in the eyes of preterm infants. It can become aggressive with retinal neovascularization and progress to retinal detachment and blindness. As smaller babies are surviving, the incidence of ROP has increased. With the tremendous therapeutic potential of endothelial progenitor cells (EPC) in the treatment of ischemic diseases, the goal of this study is to identify and characterize a subset of functional HPP-EPC from bone marrow. We will further test their ability to promote vascular regrowth and repair aberrant retinal vessels in ROP model.

Methods: : To enhance endothelial differentiation, an in vitro model with BMEC-CM was developed to induce bone marrow-derived EPC. Endothelial cell colonies (EC-cols) were cultured with BMEC-CM for 3 months. EC markers and functions, the leukocytes marker CD45 and monocytic functions were studied. The single progenitor cell growth curve was quantified. The high-proliferative potential (HPP)-EPC were isolated and characterized.

Results: : BMEC-CM treatment of bone marrow mononuclear cells showed the best induction, with EPC-colony cell expression of CD31, von Willebrand factor, UEA-1 positive, and incorporation of Ac-LDL. EPC-colony cells expressed differential proliferative capacity; the HPP-EPC were isolated, they exhibited a high proliferative capacity up to 20 population doublings resulting in 7x10^6 cells per EPC after 14 weeks incubation, and formed the capillary-like network in vitro. Moreover, HPP-EPC expressed CD45, exhibited endocytic activities, and secrete various growth factors into the culture medium.

Conclusions: : HPP-EPC were isolated and cultured with the induction of BMEC-CM. These cells showed high proliferative capacity and preserved some hematopoietic lineage characteristics. We will further test their ability to facilitate functional vessel growth in ROP model.

Keywords: retinal neovascularization • proliferation • hypoxia 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×